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436a Tuesday, February 28, 2012sarcomere function with consequences for in vivo cardiac performance. The
functional role of cMyBP-C is tightly regulated by kinase-mediated phosphor-
ylation, of which protein kinase A (PKA)-mediated phosphorylation is impor-
tant during cardiac stress and exercise. To date, three serines have been
identified on which cMyBP-C can be phosphorylated in vivo, all of which
are located in the cardiac isoform specific M region, i.e. Ser273, Ser282 and
Ser 302. However, previous experiments have indicated that at least one
more phosphorylation site should exist in humans. The aim of the present study
was to identify the unknown phosphorylation site on human cMyBP-C.
cMyBP-C was semi-purified from human non-failing donor and end-stage fail-
ing cardiac tissue. Tandem mass spectrometry was used to identify phosphor-
ylation sites. Besides the already known Ser282 site, a phosphorylation site was
detected on Ser133 in donor tissue. For characterization of this site, a phospho-
specific antibody was developed. Levels of Ser133 phosphorylation are lower
in end-stage heart failure samples as well as in samples from hypertrophic
and dilated cardiomyopathy patients compared to donor. Initial experiments
suggest that unlike the three previously known phosphorylation sites, Ser133
is not phosphorylated by PKA.
In conclusion, we identified a fourth phosphorylation site (Ser133) in human
cMyBP-C, which is present in the Pro-Ala rich region that links the C0 and
C1 domains. This site is less phosphorylated in various cardiac pathologies
and does not seem to be a target of PKA.
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Cardiac myosin binding protein-C (cMyBP-C), a sarcomeric protein with 11
domains- C0-C10, binds myosin LMM via its C-terminus, while its N-terminus
binds both myosin S2 and actin. These N-terminal interactions can be attenu-
ated by phosphorylation of serines within the C1-C2 linker. In vivo, cMyBP-
C exists in a range of phosphorylation states, which may alter its regulation
of actomyosin. Therefore, N-terminal fragments (C0-C3) of cMyBP-C were
bacterially expressed with one or more phosphorylatable serines (S273,
S282, S302) mutated to either alanines to mimic dephosphorylation or
aspartic acids as phosphomimetics. Using C0-C3 fragments that were effec-
tively mono-, di- or tri-phosphorylated, we characterized how the extent of
cMyBP-C phosphorylation modulated the the force:velocity relationship gener-
ated by a small ensemble (~8 motors) of skeletal muscle myosin in the load-
clamped laser trap assay. Mono-phosphorylated C0-C3 inhibited unloaded
velocity by 70% as did unphosphorylated C0-C3, while di- and tri-
phosphorylated constructs were indistinguishable and less inhibitory (30%).
Maximal force was unaffected by the extent of phosphorylation. Thus, the
un- and mono-phosphorylated C0-C3 constructs depressed the force-velocity
relationship, which was well fitted by a modified Hill equation containing an
assumed viscous load due to C0-C3 binding to actin (Weith et al., 2011). In
addition, both un- and mono- phosphorylated C0-C3 reduced peak power by
~40%, while neither di- nor tri-phosphorylated C0-C3 had any effect on peak
power. cMyBP-C phosphorylation appears to modulate cMyBP-C’s inhibition
of actomyosin power generation in an ‘‘on/off’’ manner.
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Enhanced cardiac contractility results from phosphorylation within the
cMyBP-C motif domain by affecting the interaction of cMyBP-C’s N-terminus
with actin and/or myosin. We investigated whether motif (i.e. C1C2 linker)
phosphorylation alters its structural conformation by characterizing the force-
extension behavior of expressed N-terminal cMyBP-C fragments (i.e.C0C3)
that contain the motif using atomic force spectroscopy. Proteins were adsorbed
onto glass slides, bound non-specifically to SiNi AFM probes, and stretched at
700nm/s. Force-extension traces showed the characteristic sawtooth shape of
unfolding immunoglobulin domains, and were well fitted by the wormlike
chain model. The model fits produced a median persistence length of 0.36nm
and an average C0C3 contour length of 71.5nm, suggesting that the motif is dis-ordered and freely extensible when unphosphorylated. PKA phosphorylation
did not change immunoglobulin unfolding force or persistence length but de-
creased the contour length by 27nm, suggesting that the motif assumed a folded
configuration that is stable under load. This was investigated further by varying
the extent of phosphorylation using phosphomimetic mutants, in which serines
273, 282, and 302 were replaced with different combinations of alanines or as-
partic acids in order to mimic the unphosphorylated and phosphorylated states
respectively. While substitution with all alanines or all aspartic acids produced
similar results to the control and PKA treated fragments respectively, phos-
phorylation at only one or two sites did not reduce contour length significantly.
This implies that phosphorylation at all three sites is required for motif folding
to be stable under load, while partial phosphorylation may result in a fold which
is readily extended at low force. In conclusion, cMyBP-C phosphorylation
could modulate the cMyBP-C’s N-terminal domain interactions with actin
and/or myosin by folding the motif in such a way that binding sites for actin
and/or myosin are hidden.
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Titin is a giant protein that functions as a molecular spring and contributes to
the passive diastolic stiffness of the left ventricle (LV). Titin’s spring region
consists of three sequence elements: the tandem Ig, the N2B and the PEVK el-
ements. Mouse models exist in which either of the latter two elements (N2B
KO, PEVK KO) has been deleted, but considering that these elements are
also likely to play roles in signaling, we made a model in which we deleted
2/3 of the proximal tandem Ig element (IGKO), a region that is not known to
contain signaling functions. Homozygous KO mice survive to adulthood and
are fertile with no change in LV Weight to Body Weight (LVW/BW) ratio
(3.6750.07mg/g WT vs 3.5150.04mg/g IgKO). A custom titin exon microar-
ray confirmed the deletion of the expected exons with no other changes. Gel
electrophoresis showed that the IGKO expresses an 88kDa smaller titin isoform
but no other changes in isoform expression. Immuno-electron microscopy indi-
cates that the remaining spring elements extend to a higher degree than in WT
myocardium. Mechanical measurements in cardiomyocytes (see also poster by
Methawasin) and myofibers show that the deletion increases passive stiffness in
titin in a sarcomere length dependence manner, without adaptations in the pas-
sive stiffness of the extracellular matrix. Initial isolated intact heart data and
in-vivo pressure volume measurement suggest that the IGKO has increased
stiffness in-vivo. Further phenotypic characterization is currently underway.
In summary, shortening the proximal tandem Ig element of titin produces a
diastolic stiffness phenotype.Platform: Mitochondria in Cell Life & Death
2215-Plat
VDAC Phosphorylation in Control of Mitochondrial Respiration
Kely L. Sheldon1,2, Eduardo N. Maldonado3, John J. Lemasters3,
Sergey M. Bezrukov1, Tatiana K. Rostovtseva1.
1Program in Physical Biology, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, National Institutes of Health,
Bethesda, MD, USA, 2W. Harry Feinstone Department of Molecular
Microbiology and Immunology, Johns Hopkins University Bloomberg
School of Public Health, Baltimore, MD, USA, 3Medical University
of South Carolina, Charleston, SC, USA.
Tubulin has been recently identified as a powerful regulator of voltage depen-
dent anion channel (VDAC). Dimeric tubulin induces reversible blockage of
VDAC reconstituted into planar lipid membranes and blocks the flux of
ATP/ADP across the mitochondrial outer membrane. Here we show that phos-
phorylation of VDAC by cytosolic kinases protein kinase A (PKA) and glyco-
gen synthase kinase-3b (GSK3b) increases the on-rate of tubulin binding by
orders of magnitude, but only for tubulin at the cis (or cytosolic) side of the
membrane. This and the fact that the basic properties of VDAC, such as
single-channel conductance and selectivity, remained unaltered by phosphory-
lation allowed us to suggest the phosphorylation regions positioned on the
cytosolic loops of VDAC and establish channel orientation in our reconstitution
experiments. Experiments on human hepatoma cells HepG2 are in agreement
with our findings that phosphorylation state of VDAC determines its blockage
by tubulin. When HepG2 cells were treated with the microtubule-destabilizing
